Spain· ES:1231787001
CASGEVY 4 - 13 × 10E6 CELULAS/ML DISPERSION PARA PERFUSION
A medicinal product containing exagamglogén autotemcel, registered in Spain by Vertex Pharmaceuticals (Ireland) Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- exagamglogén autotemcel
- Manufacturer
- Vertex Pharmaceuticals (Ireland) Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Exagamglogén autotemcel in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCASGEVYVertex Pharmaceuticals Incorporated
- SwitzerlandCasgevy 4-13 x 10e6 cells/ml, InfusionsdispersionVertex Pharmaceuticals (CH) GmbH
- CzechiaCASGEVYVertex Pharmaceuticals (Ireland) Limited, Dublin
- FinlandCasgevyVertex Pharmaceuticals (Ireland) Limited
- FranceCASGEVY 4 à 13 x 1 000 000 cellules/mL, dispersion pour perfusionVERTEX PHARMACEUTICALS (EUROPE) LIMITED
- United KingdomCasgevy 4million-13million cells/ml dispersion for infusion vialsVertex Pharmaceuticals (Europe) Ltd
- BelgiumCasgevy 4 10*6 cells/ml - 13 10*6 cells/mlVertex Pharmaceuticals (Ireland)
- IcelandCasgevyVertex Pharmaceuticals (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Casgevy
- Liechtenstein · Casgevy
- Norway · Casgevy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/163517b4-1a7d-4784-af43-e54252fd62ad GET /v1/drugs/163517b4-1a7d-4784-af43-e54252fd62ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1709291137000}",
"nregistro": "1231787001",
"substance": "exagamglogén autotemcel"
}See everything about exagamglogén autotemcel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.